Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.1 EUR
488.77 M EUR
19.06 B EUR
586.39 M
About FRESEN.MED.CARE KGAA O.N.
Sector
Industry
CEO
Helen Giza
Website
Headquarters
Bad Homburg
Founded
2006
FIGI
BBG000L63T41
Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcare products business including research and development, manufacturing, supply chain, and commercial operations as well as supporting functions, such as regulatory and quality management. The Care Delivery segment focuses on the health care services for the treatment of CKD, ESRD, and other extracorporeal therapies, including value and risk-based care programs. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
F
US35805BAA61
FreMedCarUSFin3 3,75% 15/06/2029 Rule 144AYield to maturity
5.40%
Maturity date
Jun 15, 2029
F
FMS5184425
Fresenius Medical Care US Finance III, Inc. 3.0% 01-DEC-2031Yield to maturity
5.17%
Maturity date
Dec 1, 2031
F
FMS5184423
Fresenius Medical Care US Finance III, Inc. 1.875% 01-DEC-2026Yield to maturity
5.17%
Maturity date
Dec 1, 2026
Explore more bonds